✦ LIBER ✦

Randomised clinical trial: the safety and efficacy of long-acting octreotide in patients with portal hypertension

✍ Scribed by N. Chandok; P. S. Kamath; A. Blei; J. Bosch; W. Carey; N. Grace; K. V. Kowdley; K. Benner; R. J. Groszmann

Book ID: 108606649
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 225 KB
Volume: 35
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2012.05050.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A prospective, multicentre study to inve

A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR® (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly

✍ Moises Mercado; Fatima Borges; Hakim Bouterfa; Tien-Chun Chang; Alberto Chervin; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB

The efficacy of octreotide LAR (long act

The efficacy of octreotide LAR (long acting release) treatment in patients with somatotropinoma, and mixed pituitary tumours

✍ Waśko, Ryszard ;Bolko, Paweł ;Owecki, Maciej ;Jaskuła, Magdalena ;Sowiński, Jerz 📂 Article 📅 2004 🏛 Springer 🌐 Dutch ⚖ 99 KB

Efficacy and safety of long-acting rispe

Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder

✍ Robert A. Lasser; Cynthia A. Bossie; Young Zhu; Georges Gharabawi; Mariëlle Eerd 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Long‐acting risperidone, the first long‐acting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi

Randomised clinical trial: the efficacy

Randomised clinical trial: the efficacy and safety of propionyl-l-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment

✍ T. L. Mikhailova; E. Sishkova; E. Poniewierka; K. P. Zhidkov; I. G. Bakulin; L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB

Safety and efficacy of long-acting injec

Safety and efficacy of long-acting injectable risperidone in patients with schizophrenia spectrum disorders: A 6-month open-label trial in Asian patients

✍ Swapna Verma; Mythily Subramaniam; Edimansyah Abdin; Kang Sim; Alex Su; Nelson L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Abstract The study aimed to evaluate the efficacy of long‐acting injectable risperidone (LAR) in Asian patients with schizophrenia spectrum disorders. Twenty‐five patients enrolled in this 6‐month open labelled study. They were switched from their current antipsychotic to LAR without a prior or

A randomized, controlled, multicentre tr

A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly

✍ Peter J. Trainer; Shereen Ezzat; Gwyn A. D’Souza; Gary Layton; Christian J. Stra 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB